Boule Diagnostics AB
BOUL.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$93.98M
Close$
Share Statistics
| Market cap | $93.98 Million |
|---|---|
| Enterprise Value | $301.68 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.1 |
| Beta | 0.17 |
| Outstanding Shares | 38,833,104 |
Return
| Return on Equity | -2.17% |
|---|---|
| Return on Assets | -0.79% |
| Return on Invested Capital | 8.21% |
Valuation & Multiples
| P/E Ratio | -23.31 |
|---|---|
| PEG | 33.22 |
| Price to Sales | 0.21 |
| Price to Book Ratio | 0.57 |
| Enterprise Value to Revenue | 0.65 |
| Enterprise Value to EBIT | 13.9 |
| Enterprise Value to Net Income | -80 |
| Total Debt to Enterprise | 0.75 |
| Debt to Equity | 1.3 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 17, 2026
EPS Estimate
$0.01
Average shareholder expectationRevenue Estimate
$114.50 M
Average shareholder expectationNext Earnings Call
Expected Date
October 23, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$111.50 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Boule Diagnostics AB
200 employees
CEO: Johan Folkunger Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. ...